Literature DB >> 25944128

Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the Perugia General Practitioner Study.

Valentina Salvatori1, Cecilia Becattini, Stefano Laureti, Gregorio Baglioni, Fabrizio Germini, Piero Grilli, Francesco Guercini, Esmeralda Filippucci, Giancarlo Agnelli.   

Abstract

Atrial fibrillation (AF) is diagnosed for the first time in about 5 % of patients admitted for acute ischemic stroke. Advanced aged and arterial hypertension are risk factors for AF. We evaluated the prevalence of silent AF in subjects with advanced age and systemic arterial hypertension. Subjects of both gender, aged 65 years or more with systemic arterial hypertension were randomly identified from the patient lists of the participating general practitioners in the Perugia area, in Italy. Study subjects underwent baseline 12-lead ECG and, if this did not show AF, 48-h Holter monitoring was performed. AF was known and confirmed by 12-lead ECG in 4 out of the 308 evaluated subjects (1.3 %). Baseline 12-lead ECG showed no cases of silent AF. Holter monitoring was performed in 300 subjects, mean age 70 ± 4. Twenty-six recordings were not evaluable for the presence of artifacts; therefore, 274 subjects were included in the analysis. Holter monitoring showed AF in 27 out of 274 subjects (10 %; 95 % confidence interval 6.4-13.5 %); AF was longer than 30 s in four of the subjects. In 56 additional subjects, Holter monitoring revealed excessive supraventricular ectopic activity (20 %; 95 % confidence interval 15.3-24.7 %). Holter monitoring was able to detect silent AF in about 10 % of subjects aged 65 or above with systemic arterial hypertension. The risk of stroke associated with screened silent AF should be carefully evaluated.

Entities:  

Mesh:

Year:  2015        PMID: 25944128     DOI: 10.1007/s11739-015-1241-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  34 in total

1.  Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.

Authors:  David A Fitzmaurice; F D Richard Hobbs; Sue Jowett; Jonathon Mant; Ellen T Murray; Roger Holder; J P Raftery; S Bryan; Michael Davies; Gregory Y H Lip; T F Allan
Journal:  BMJ       Date:  2007-08-02

2.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Authors:  F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

3.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

4.  Atrial fibrillation detection after cryptogenic stroke.

Authors:  Maddalena Alessandra Wu; Emanuela Scannella
Journal:  Intern Emerg Med       Date:  2014-10-02       Impact factor: 3.397

5.  Atrial fibrillation: a comparison of methods to identify cases in general practice.

Authors:  S Somerville; J Somerville; P Croft; M Lewis
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

Review 6.  Epidemiology and significance of atrial fibrillation.

Authors:  K M Ryder; E J Benjamin
Journal:  Am J Cardiol       Date:  1999-11-04       Impact factor: 2.778

7.  Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome.

Authors:  M Paciaroni; G Agnelli; V Caso; M Venti; P Milia; G Silvestrelli; L Parnetti; S Biagini
Journal:  J Thromb Haemost       Date:  2005-05-09       Impact factor: 5.824

Review 8.  Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review.

Authors:  Joy Liao; Zahira Khalid; Ciaran Scallan; Carlos Morillo; Martin O'Donnell
Journal:  Stroke       Date:  2007-09-27       Impact factor: 7.914

9.  Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.

Authors:  David Conen; Usha B Tedrow; Bruce A Koplan; Robert J Glynn; Julie E Buring; Christine M Albert
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  5 in total

1.  Atrial fibrillation in organ transplant recipients: only a marker of the underlying disease?

Authors:  Francesca Innocenti; Riccardo Pini
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

Review 2.  Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact.

Authors:  Polychronis E Dilaveris; Harold L Kennedy
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

3.  The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.

Authors:  Pietro Amedeo Modesti; Gianni Donigaglia; Plinio Fabiani; Nicola Mumoli; Andrea Colella; Maria Boddi
Journal:  Intern Emerg Med       Date:  2017-09-19       Impact factor: 3.397

4.  Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset.

Authors:  Aatish Garg; Monica Khunger; Sinziana Seicean; Mina K Chung; Patrick J Tchou
Journal:  JACC Clin Electrophysiol       Date:  2016-04-06

5.  Atrial fibrillation detection using single lead portable electrocardiographic monitoring: a systematic review and meta-analysis.

Authors:  Satish Ramkumar; Nitesh Nerlekar; Daniel D'Souza; Derek J Pol; Jonathan M Kalman; Thomas H Marwick
Journal:  BMJ Open       Date:  2018-09-17       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.